Publications by authors named "Giulia Alberti"

Claim this Profile
A
A New Era, New Risks: The Cardio-Oncology Perspective on Immunotherapy in Non-Small Cell Lung Cancer.
Luigi Tarantini, Giuseppina Gallucci, Alessandro Inno, Andrea Camerini, Maria Laura Canale, Giulia Alberti

Cancers (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Successful percutaneous treatment of complex heart disease in a stage IV non-small cell lung cancer survivor].
Davide Bosi, Pierluigi Demola, Giulia Alberti, Sergio Musto D'Amore, Mario Larocca

G Ital Cardiol (Rome)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry Experience.
Kalliopi Andrikou, Paola Ulivi, Elisabetta Petracci, Irene Azzali, Federica Bertolini, Giulia Alberti

Diagnostics (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in the Histology of Lung Cancer in Northern Italy: Impact on Incidence and Mortality.
Lucia Mangone, Francesco Marinelli, Isabella Bisceglia, Alessandro Zambelli, Francesca Zanelli, Giulia Alberti

Cancers (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 expression in gastroesophageal dysplastic lesions.
Matteo Fassan, Stefano Brignola, Gianmaria Pennelli, Giulia Alberti, Valentina Angerilli

Virchows Arch· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trial.
Giuseppe Pasqualetti, Marta Schirripa, Emmanuelle Dochy, Matteo Fassan, Pina Ziranu, Giulia Alberti

Eur J Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib.
Alessio Amatu, Marta Schirripa, Federica Tosi, Sara Lonardi, Katia Bencardino, Giulia Alberti

Front Oncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ramucirumab: the long and winding road toward being an option for mCRC treatment.
Celine Debeuckelaere, Sabina Murgioni, Sara Lonardi, Noemi Girardi, Giulia Alberti

Expert Opin Biol Ther· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study.
Marta Schirripa, Giuseppe Pasqualetti, Riccardo Giampieri, Mario Scartozzi, Sara Lonardi, Giulia Alberti

Clin Colorectal Cancer· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients.
Marta Schirripa, Wu Zhang, Dongyun Yang, Shu Cao, Satoshi Okazaki, Giulia Alberti

PLoS One· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis